August 19, 2020, Dusseldorf, Germany – MLM Medical Labs GmbH (“MLM”), a Great Point Partners (“GPP”) portfolio company, today announced that Isabel Struik has joined the team as VP Sales & Marketing.
MLM Medical Labs appoints Isabel Struik as VP Sales & Marketing Read More »
July 8, 2020, Dusseldorf, Germany – MLM Medical Labs GmbH (“MLM”), a Great Point Partners (“GPP”) portfolio company, today announced the acquisition of CirQuest Labs, based in Memphis, TN, USA.
MLM Medical Labs expands to the US and nominates Thomas Wollman as member of the board Read More »
The globalization of clinical research has seen international multicenter trials become standard, partially in response to the increasing demand to clinical trials that cover the three major markets:
Expansion of central lab services to China Read More »
Mönchengladbach, April 15, 2019 – The Innovative Medicines Initiative (IMI) today announced the launch of the Translational Safety Biomarker Pipeline (TransBioLine) Project, a five-year program to
On September 8th the MLM company premises turned into a summer festival area. On the occasion of its 25th company anniversary all shareholders, employees and their families were invited to a
MLM team celebrates 25th anniversary Read More »
